Clinical Trials Logo

Metabolites clinical trials

View clinical trials related to Metabolites.

Filter by:
  • None
  • Page 1

NCT ID: NCT06098001 Active, not recruiting - Bioavailability Clinical Trials

Bioavailability Study of Hemp Phenolics

Start date: September 15, 2023
Phase: N/A
Study type: Interventional

The aim is to determine the bioavailability of the polyphenol fraction form a commercially available hemp hull fiber at two different amounts in generally healthy adults. Additional objectives include determining specific metabolites produced over a 24 to 48-hour period following the hemp fiber consumption. Subjects will consume a study pudding that will be used to deliver a low and a high dose fiber product. Blood samples will be collected to measure background levels of metabolites. At day 0 participants will consume a low dose study product and day 6 the high dose study product and provide blood samples over an 8 hr period after study product consumption, to be followed by a 24 hr blood sample and 48 hr blood sample. Additionally following the low / high dose study product 24 and 48 h urine samples will be collected.

NCT ID: NCT05551923 Recruiting - Gut Microbiota Clinical Trials

Predictive Value of Human Microbiome and Serological Markers for Clinical Outcome of Cerebral Hemorrhage

Start date: August 14, 2020
Phase:
Study type: Observational

Objective: To explore the predictive value of characteristic disorder of intestinal flora for clinical prognosis in patients with intracerebral hemorrhage. Secondary objectives: 1) To investigate the correlation of gut microbiota and its serological indicators with imaging features and clinical neurological deficits in ICH; 2) Dynamically observe the changes of human microbiome and its serological indicators after ICH, and explore the biomarkers based on human microbiome related to disease changes.

NCT ID: NCT05481866 Not yet recruiting - Gut Microbiota Clinical Trials

Targeting Gut Microbiota and Metabolites for Very Preterm Infants Through Oropharyngeal Administration of Colostrum

Start date: October 2022
Phase: N/A
Study type: Interventional

Background: Oropharyngeal administration of colostrum (OAC) has an immune stimulating effect on oropharyngeal-associated lymphoid tissue, and can also promote the maturation of the gastrointestinal tract. However, how OAC promotes intestinal maturation in preterm infants by altering the gut microbiota remains unclear. We aim to assess the changes of gut microbiota and metabolites after OAC in very preterm infants. Methods: A multicenter, double-blind, randomized controlled trial will be conducted in 3 large NICUs in Shenzhen, China, for preterm infants with gestational age less than 32 weeks and birth weight less than 1500g. The intervention group will be given 0.2ml colostrum for oropharyngeal administration every 3 hours, which will start between the first 48 to 72 hours and continue for 5 consecutive days; The control group will be given sterile water for oropharyngeal administration, and the administration scheme will be the same as above. Stool samples will be collected at the first defecation and the 7th day after birth. It is estimated that 320 preterm infants will participate in the study within 1 year. 16sRNA gene sequencing and liquid chromatography-mass spectrometry will be used to analyze the effect of OAC on gut microbiota and metabolites. Discussion: The proposal advocates for the promotion of OAC as a safe and relatively beneficial initiative among neonatal intensive care units, and this initiative may contribute to the establishment of a dominant intestinal flora. Findings of this study may help to improve the health outcomes of preterm infants by constructing targeted gut microbiota in future studies.

NCT ID: NCT05076864 Recruiting - Acute Kidney Injury Clinical Trials

Levosimendans Pharmacokinetics in Intensive Care Patients. An Observational Study.

LEFKIP
Start date: January 1, 2020
Phase:
Study type: Observational

Evaluation of the pharmacokinetics of levosimendan and its metabolites in intensive care patients with normal, reduced and dialysis supported renal function.

NCT ID: NCT04315038 Completed - Aging Clinical Trials

Metabolomics Profiling Research of Human Cerebrospinal Fluid in Aging Process

Start date: August 1, 2019
Phase:
Study type: Observational

Perform quantitative metabolomics on human cerebrospinal fluid (CSF) samples and establish the first human CSF Metabolome Database of aging process in Taiwan.

NCT ID: NCT03746158 Completed - Gut Microbiota Clinical Trials

Interindividual Variation in Excretion of Curcumin

Start date: September 1, 2018
Phase: N/A
Study type: Interventional

The objective of this project is to elucidate the interindividual variations in excretion of curcumin and its metabolites.

NCT ID: NCT01719393 Not yet recruiting - Pulmonary Function Clinical Trials

Pulse Spectrum Analysis in Adult Asthmatics: Correlation With Lung Function, Asthma Control Exhaled Nitric Oxide and Metabolites in Exhaled Breath Condensate

Start date: November 2012
Phase: N/A
Study type: Observational

Our hypothesis is that radial arterial pulse may reflect the severity and airway function in asthmatics. The aims of this study are to investigate the pulse spectrim of the radial artery in adult asthmatics, and evaluate its correlation with airy inflammation an lung funtion in asthmatics.